"Stacy is joining Upstream Bio at a pivotal time in our growth as we prepare to initiate a third clinical program for ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter ...

Invivyd Inc (IVVD) reports a 15% reduction in operating expenses and explores new viral targets, while navigating sales transitions and regulatory hurdles.

Katie Falzone; Senior Vice President, Finance; Invivyd Inc. Marc Elia; Independent Chairman of the Board; Invivyd Inc. Tim Lee; Chief Commercial Officer; Invivyd Inc ...

Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ETCompany ParticipantsKatie Falzone - Senior Vice President, ...

MEC175xB controllers are currently available as part of Microchip's early adopter program. For additional information, ...

PEMGARDA™ (pemivibart) net product revenue of $11.3 million reported for Q1 2025, influenced by planned transition (Jan/Feb) from a contracted to an internalized sales forcePEMGARDA revenue ...

Analysts are estimating that Invivyd will report an earnings per share (EPS) of $-0.01. Invivyd bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide ...

Invivyd initiates new pipeline discovery programme focused on monoclonal antibody treatment for measles: Waltham, Massachusetts Tuesday, May 13, 2025, 16:00 Hrs [IST] Invivyd, Inc ...

Retail buzz around Invivyd Inc. spiked on Monday after it revealed its launch of a discovery program to create a ...

Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine ...

Los Angeles Chargers Head Coach Jim Harbaugh joins Newsweek Sports to provide some big health updates, breaks down 2025 draft ...